Market Cap (In TWD)
2.33 Billion
Revenue (In TWD)
810.91 Million
Net Income (In TWD)
61.98 Million
Avg. Volume
138.2 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 48.95-71.1
- PE
- -
- EPS
- -
- Beta Value
- 0.196
- ISIN
- TW0008432006
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Sze-Yuan Yang
- Employee Count
- -
- Website
- https://www.tshbiopharm.com
- Ipo Date
- 2012-04-30
- Details
- TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan and Asia. It offers products for cardiovascular, central nervous, gastrointestinal, and others. The company was founded in 1999 and is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.
More Stocks
-
BIOG
-
EEGUF
-
MTOMitie Group plc
MTO
-
INPSTInPost S.A.
INPST
-
SSNC
-
3422J-MAX Co.,Ltd.
3422
-
5230Ledlink Optics, Inc.
5230
-
BBY